These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 32782442

  • 1. Allergic rhinitis and asthma symptoms in a real-life study of MP-AzeFlu to treat multimorbid allergic rhinitis and asthma.
    Price D, Klimek L, Gálffy G, Emmeluth M, Koltun A, Kopietz F, Nguyen DT, van Weissenbruch R, Pohl W, Kuhl HC, Scadding G, Mullol J.
    Clin Mol Allergy; 2020; 18():15. PubMed ID: 32782442
    [Abstract] [Full Text] [Related]

  • 2. Real-Life Effectiveness of MP-AzeFlu (Dymista®) in Swedish Patients with Persistent Allergic Rhinitis, Assessed by the Visual Analogue Scale.
    Stjärne P, Nguyen DT, Kuhl HC.
    Pragmat Obs Res; 2023; 14():1-11. PubMed ID: 36628265
    [Abstract] [Full Text] [Related]

  • 3. MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis.
    van Weissenbruch R, Klimek L, Gálffy G, Emmeluth M, Koltun A, Kopietz F, Nguyen DT, Kuhl HC, Pohl W, Scadding GK, Price D, Mullol J.
    J Asthma Allergy; 2020; 13():633-645. PubMed ID: 33293835
    [Abstract] [Full Text] [Related]

  • 4. MP-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Denmark.
    Haahr PA, Jacobsen C, Christensen ME.
    Int Forum Allergy Rhinol; 2019 Apr; 9(4):388-395. PubMed ID: 30659752
    [Abstract] [Full Text] [Related]

  • 5. A multicenter, prospective, noninterventional study in a Norwegian cohort of patients with moderate-to-severe allergic rhinitis treated with MP-AzeFlu.
    Dollner R, Lorentz Larsen P, Dheyauldeen S, Steinsvåg S.
    Allergy Rhinol (Providence); 2017 Oct 01; 8(3):148-156. PubMed ID: 29070272
    [Abstract] [Full Text] [Related]

  • 6. Real-life effectiveness of MP-AzeFlu in Irish patients with persistent allergic rhinitis, assessed by visual analogue scale and endoscopy.
    Kaulsay R, Nguyen DT, Kuhl HC.
    Immun Inflamm Dis; 2018 Dec 01; 6(4):456-464. PubMed ID: 30306729
    [Abstract] [Full Text] [Related]

  • 7. Multicentre, non-interventional study to assess the profile of patients with uncontrolled rhinitis prescribed a novel formulation of azelastine hydrochloride and fluticasone propionate in a single spray in routine clinical practice in the UK.
    Scadding G, Price D, El-Shanawany T, Ahmed S, Ray J, Sargur R, Kumar N.
    BMJ Open; 2017 Apr 24; 7(4):e014777. PubMed ID: 28442578
    [No Abstract] [Full Text] [Related]

  • 8. Effect of Specific Immunoglobulin E Response and Comorbidities on Effectiveness of MP-AzeFlu in a Real-Life Study.
    Klimek L, Price D, Gálffy G, Emmeluth M, Koltun A, Kopietz F, Nguyen DT, van Weissenbruch R, Pohl W, Kuhl HC, Scadding G, Mullol J.
    Int Arch Allergy Immunol; 2020 Apr 24; 181(10):754-764. PubMed ID: 32829329
    [Abstract] [Full Text] [Related]

  • 9. MP-AzeFlu provides rapid and effective allergic rhinitis control in real life: A pan-European study.
    Klimek L, Bachert C, Stjärne P, Dollner R, Larsen P, Haahr P, Agache I, Scadding G, Price D.
    Allergy Asthma Proc; 2016 Sep 24; 37(5):376-86. PubMed ID: 27657521
    [Abstract] [Full Text] [Related]

  • 10. Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care.
    De Jong HJI, Voorham J, Scadding GK, Bachert C, Canonica GW, Smith P, Wahn U, Ryan D, Castillo JA, Carter VA, Murray RB, Price DB.
    World Allergy Organ J; 2020 Dec 24; 13(12):100490. PubMed ID: 33376573
    [Abstract] [Full Text] [Related]

  • 11. An Observational Study to Determine the Real-Life Effectiveness of MP-AzeFlu® in Austrian Patients with Persistent Allergic Rhinitis.
    Marth K, Renner A, Langmayr G, Pohl W, Nguyen DT, Kuhl HC.
    Drugs Real World Outcomes; 2024 Jun 24; 11(2):231-240. PubMed ID: 38351402
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of MP-AzeFlu in children with seasonal allergic rhinitis: Importance of paediatric symptom assessment.
    Berger W, Meltzer EO, Amar N, Fox AT, Just J, Muraro A, Nieto A, Valovirta E, Wickman M, Bousquet J.
    Pediatr Allergy Immunol; 2016 Mar 24; 27(2):126-33. PubMed ID: 26928753
    [Abstract] [Full Text] [Related]

  • 13. MP-AzeFlu is more effective than fluticasone propionate for the treatment of allergic rhinitis in children.
    Berger W, Bousquet J, Fox AT, Just J, Muraro A, Nieto A, Valovirta E, Wickman M, Wahn U.
    Allergy; 2016 Aug 24; 71(8):1219-22. PubMed ID: 27043452
    [Abstract] [Full Text] [Related]

  • 14. MP-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Romania.
    Agache I, Doros IC, Leru PM, Bucur I, Poenaru M, Sarafoleanu C.
    Rhinology; 2018 Mar 01; 56(1):33-41. PubMed ID: 28942457
    [Abstract] [Full Text] [Related]

  • 15. A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic Rhinitis.
    Zhou B, Cheng L, Pan J, Wang H, Jin Y, Zhao C, Lin P, Tan G, Fang H, Zhang H, Zhou H, Dong Y, Kuhl HC, Ramalingam RK, Nguyen DT.
    Pulm Ther; 2023 Sep 01; 9(3):411-427. PubMed ID: 37580498
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate, Delivered in a Single Spray, for the Treatment of Seasonal Allergic Rhinitis: Results from Russia.
    Ilyina NI, Edin AS, Astafieva NG, Lopatin AS, Sidorenko IV, Ukhanova OP, Khanova FM.
    Int Arch Allergy Immunol; 2019 Sep 01; 178(3):255-263. PubMed ID: 30677766
    [Abstract] [Full Text] [Related]

  • 17. Control of allergic rhinitis with MP-AzeFlu: a noninterventional study of a Swedish cohort.
    Stjarne P, Strand V, Theman K, Ehnhage A.
    Rhinology; 2019 Aug 01; 57(4):279-286. PubMed ID: 30938376
    [Abstract] [Full Text] [Related]

  • 18. MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review.
    Klimek L, Berger WE, Bousquet J, Keith PK, Smith P, Sole D, Scadding G, Kuhl HC, Nguyen DT, Kopietz F, Koltun A.
    Int Arch Allergy Immunol; 2021 Aug 01; 182(11):1026-1035. PubMed ID: 34082425
    [Abstract] [Full Text] [Related]

  • 19. A Comparison of Health Care Resource Utilization and Costs for Patients with Allergic Rhinitis on Single-Product or Free-Combination Therapy of Intranasal Steroids and Intranasal Antihistamines.
    Harrow B, Sedaghat AR, Caldwell-Tarr A, Dufour R.
    J Manag Care Spec Pharm; 2016 Dec 01; 22(12):1426-1436. PubMed ID: 27882840
    [Abstract] [Full Text] [Related]

  • 20. The Use of Azelastine Hydrochloride/Fluticasone Propionate in the Management of Allergic Rhinitis in Asia: A Review.
    Tantilipikorn P, Kirtsreesakul V, Bunnag C, Vangveeravong M, Thanaviratananich S, Chusakul S.
    J Asthma Allergy; 2024 Dec 01; 17():667-679. PubMed ID: 39045291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.